Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) SHH

Currency In CNY

AD

Valuation

Market Cap8.71B
Enterprise Value7.58B
P/E Ratio-71.31
PEG Ratio0.3
Price/Sales Ratio1.47
Price/Book Ratio4.12
Enterprise/Revenue-0.34
Enterprise/EBITDA4.52

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.19
Operating Margin-0.21
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.06

Income Statement

Revenue685.8M
Revenue/Share0.64
Gross Profit616.49M
EBITDA-83.7M
Net Income-157.44M
Diluted EPS-0.15

Balance Sheet

Total Cash1.22B
Total Cash/Share1.18
Total Debt11.99M
Total Debt/Equity0.01
Current Ratio6.53
Book Value Per Share2.08

Price History

52-Week Change-6.46
52-Week High9.5
52-Week Low6.58
Moving Average 50 Days7.92
Moving Average 200 Days7.99

Statistics

Average Volume9.75M
Shares Outstanding114.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.25
Last Split FactorN/A
Last Split DateN/A
AD